This was one of the issues raised within the commission that developed the immunization strategy.
AstraZeneca’s Covid-19 vaccine is being questioned as being the least effective of those approved so far. This difference may lead a certain population to consider rejecting it, something that certain professional groups have already considered. But nevertheless, even if a person from a priority group rejects his antigen he will not receive any ‘punishment’. On the contrary: to those who do it and request the vaccine later they will be prioritized.
It should be remembered that in Spain vaccination is voluntary, so anyone can refuse to be administered the antigen against Covid-19. As Federico de Montalvo, president of the Bioethics Council of Spain, explained to Invertia, “the fact that someone refuses to be immunized It does not imply that when you ask for it, it is not administered“.
This was one of the issues raised within the commission that developed the immunization strategy. “We debated what to do with people who rejected the antigen and it was decided that when they asked for it, they had to be prioritized.”
That is to say, “they will not be sent to the end of the row as if it were a punishment, at least in the current context“, In which priority is being given in the vaccination campaign to the most vulnerable population and essential groups such as police, civil guard, firefighters, teachers and health personnel, among others.
The possible approach by certain population groups to reject the AstraZeneca vaccine due to its lower effectiveness is “absurd, not very intelligent and not very supportive“. That is how forceful De Montalvo has been, who affirms that the antigen from the Anglo-Swedish pharmaceutical company “has followed the same controls and its lower effectiveness does not mean lack of protection against the virus.”
AstraZeneca’s was called to be the antigen that would promote mass vaccination in Spain. However, its lower effectiveness has raised doubts among the professional groups who will be inoculated.
It should be remembered that the Public Health Commission recommended not to use this vaccine in people over 55 years of age, so Health has decided to use the doses in people up to 55 years of age from the Security Forces and Bodies, emergency personnel, armed forces, teachers and second-line health and social-health personnel.
It is the solution that has been adopted momentarily due to the lack of data on the efficacy of this vaccine in older people. On the other hand, the Minister of Health, Carolina Darias, has opened the door to administer the AstraZeneca vaccine to those over 55 years of age from the month of March.
Among those who have expressed their discontent are the sanitary. The president of the General Council of Dentists, Dr. Óscar Castro, told Invertia to inoculate this antigen to second-line health personnel and essential groups (only in people up to 55 years of age) “It does not seem the most correct to me because it has shown less effectiveness than that of Pfizer or Moderna“.
Doubts about the AstraZeneca vaccine have also proliferated in one of the main recipients of these doses: the State Security Forces and Bodies. Although the agents have welcomed the news, dozens of them expressed their uncertainty as to its potential and effectiveness.
These groups may consider rejecting it and asking to be vaccinated after a while in the hope that they will do so with another of the available antigens. But nevertheless, “It may be that when they request immunization they are touched again with the same antigen”. It should be remembered that the population cannot choose the vaccine they want to be inoculated. In addition, Federico de Montalvo warns that in the time that elapses until he requests the antigen again “the person also risks catching the virus”.
For the president of the Bioethics Committee of Spain to reject the AstraZeneca vaccine “it is an unwise decision”. He has insisted that “although the percentage of effectiveness is lower, it does not mean that it does not protect and that it does not have a good rate of effectiveness.”
This was also pointed out by María Jesús Lamas, the director of the Spanish Agency for Medicines and Health Products (AEMPS) in an interview with EL ESPAÑOL in which He rejected the idea that the AstraZeneca vaccine was “the worst” of the lot.
“That the first two that have been authorized have average efficiencies of around 95% greatly affects the result of the following, because a vaccine with 60% or 70% protection is a very good vaccineHe explained.